缅北禁地

Video on drugs and COVID-19

Conferences | Drug Control

BACKGROUND

In 1961, the United Nations began holding periodic conferences on the issue of drug control. These conferences led to three major international drug control treaties.

The first of these treaties, the  was adopted at a 缅北禁地Conference In March 1961 in New York. The Convention aimed to combat drug use through coordinated international intervention. It is intended to limit the possession, consumption, trade, distribution, import, export, manufacture and production of drugs only for medical and scientific purposes. It was also meant to fight against drug trafficking through international cooperation to deter drug traffickers. In 1972, at a 缅北禁地Conference in Geneva, the Single Convention on Narcotic Drugs was modified by the .

The  was adopted at a 缅北禁地conference in 1971 in Vienna. The Convention established an international control system for psychotropic substances. It responded to the diversification and expansion of the number of drugs giving rise to illicit use and set up controls on a number of synthetic drugs according to their potential for illicit use on the one hand and their value. therapeutic on the other hand.

One of the major objectives of the first two treaties was to codify control measures to be applied at the international level to ensure the availability of narcotic drugs and psychotropic substances for medical and scientific purposes, and to prevent any diversion into illicit channels. These treaties also include general provisions on drug trafficking and abuse.

At a United Nations Conference in 1988 in Vienna the was adopted. The Convention provided pragmatic measures against drug trafficking, including provisions against money laundering and the diversion of precursor chemicals and international cooperation through controlled deliveries and prosecution transmissions.

These three conventions established the major drug control treaties still in use to this day. The 缅北禁地General Assembly then convened extraordinary sessions on the issue of drug control. The first GA special session opened on the theme of drug abuse on 20 February 20 1990 in New York. Member States were concerned about the growing scale of the illicit demand, production, supply, trafficking and distribution of narcotic drugs and psychotropic substances. The United Nations was alarmed by these threats to the health and well-being of mankind as well as the stability of nations, political, economic, social and cultural structures of all societies.

The United Nations proclaimed at the end of this session that the period 1991-2000 would be the . In addition, this session approved the to combat the drug scourge.

The second extraordinary GA session took place in June 1998, to review the fight against the illicit production, sale, demand, trafficking and distribution of narcotic drugs and psychotropic substances and its related activities, and proposed new and special measures to strengthen international cooperation in the face of the problem of illicit drugs.

The General Assembly held a Special Session on the world drug problemfrom 19-26 April 2016, in New York, to take stock of the implementation of the Political Declaration and Plan of Action on International Cooperation for an Integrated and Balanced Strategy to Combat the World Drug Problem. The session resulted in an important document, .

THE WORLD DRUG REPORT 2020

Presented in six separate booklets, the World Drug Report 2020 published by the United Nations Office on Drugs and Crime provides a wealth of information and analysis to support the international community in implementing operational recommendations on a number of commitments made by Member States, including the recommendations contained in the outcome document of the special session of the General Assembly on the world drug problem, held in 2016.  provides a summary of the five subsequent booklets.  focuses on drug demand and contains a global overview of the extent of and trends in drug use, including drug use disorders, and its health consequences.  deals with drug supply.  addresses a number of cross-cutting issues, including the macrodynamics that are driving the expansion and increasing complexity of the drug markets.  looks at the association between socioeconomic characteristics and drug use disorders, and  addresses a number of other drug policy issues that all form part of the international debate on the drug problem. (See more at .

UNODC: THE DRUG CONVENTION GUARDIAN

The  was established in 1997 as a result of the merging of the United Nations Centre for International Crime Prevention and the United Nations International Drug Control Programme, in order to focus and enhance its capacity to address the interrelated issues of drug control, crime and international terrorism in all its forms.

UNODC is the guardian of most of the conventions related to these issues, including the international drug control conventions which resulted from 缅北禁地drug conferences.

During the COVID-19 pandemic, UNODC continued to focus on delivering vital assistance to those in need, including to people who use drugs and with drug use disorders, who are in prison and who have HIV/Hepatitis C, specific pockets of vulnerability that need to be focused on in order to help slow the spread of the pandemic.

COVID-19 and drug use

According to the published by the United Nations Office on Drugs and Crime (UNODC), drug use around the world has been on the rise, in terms of both overall numbers and the proportion of the world’s population that uses drugs. In 2009, the estimated 210 million users represented 4.8 per cent of global population aged 15?64, compared with the estimated 269 million users in 2018, or 5.3 per cent of the population. Drug use is higher in urban areas than in rural areas, in both developed and developing countries. The effect of COVID-19 pandemic on drug markets is unknown and hard to predict but it could be far reaching. 

Due to COVID-19, traffickers may have to find new routes and methods, and trafficking activities via the darknet and shipments by mail may increase, despite the international postal supply chain being disrupted. The pandemic has also lead to opioid shortages, which in turn may result in people seeking out more readily available substances such as alcohol, benzodiazepines or mixing with synthetic drugs. More harmful patterns of use may emerge as some users switch to injecting, or more frequent injecting. Looking at further effects of the current pandemic, the Report says that if governments react the same way as they did to the economic crisis in 2008, when they reduced drug-related budgets, then interventions such as prevention of drug use and related risk behaviours, drug treatment services, the provision of naloxone for management and reversal of opioid overdose could be hard hit. Interception operations and international cooperation may also become less of a priority, making it easier for traffickers to operate.

The Executive Director of the 缅北禁地Office on Drugs and Crime, Ghada Waly says “Vulnerable and marginalized groups, youth, women and the poor pay the price for the world drug problem. The COVID-19 crisis and economic downturn threaten to compound drug dangers further still, when our health and social systems have been brought to the brink and our societies are struggling to cope. We need all governments to show greater solidarity and provide support, to developing countries most of all, to tackle illicit drug trafficking and offer evidence-based services for drug use disorders and related diseases, so we can achieve the Sustainable Development Goals, promote justice and leave no one behind.”